clinical

Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of 

Articles

The newly formed Bespoke Gene Therapy Consortium (BGTC) will team up to beat rare diseases that are currently using gene therapy.

Research giants team up to investigate effective gene therapies for rare diseases

Researchers at the University of Virginia School of Medicine have made a discovery linking lupus, a potentially debilitating autoimmune disorder, and macular degeneration, a leading cause of blindness.

Discovery links lupus and macular degeneration

Current options, challenges in developing novel therapies.

Sustained drug delivery in ophthalmology

Electronic health records may be the future of practice management.

COVID-19 pandemic highlights the power of electronic health records

Under terms of the agreement, ImprimisRx to assume full responsibility for US sales and marketing activities for Dexycu.

ImprimisRx and EyePoint Pharmaceuticals expand commercial alliance for Dexycu

Videos

Dr. McDonnell highlights inspiring moments from the 2021 annual meeting of the American Academy of Ophthalmology, along with a look ahead to next year’s conference in Chicago.

AAO 2021 reinvigorates ophthalmologists for 2022

Novartis has revealed the first interpretable results from year two (week 100) of the Phase III KESTREL study.

Phase 3 of KESTREL study: Novartis announces positive results for Beovu for treatment of DME

Closing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape. 

Clinical Implications of Port Delivery System in Retinal Diseases

A pilot study tests the technology to obtain remote fundus imaging of patients.

Telemedicine enhanced by robotically aligned OCT

Retinal and choroidal changes were observed in study.